Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Accured Expenses (2016 - 2025)

China Pharma Holdings filings provide 16 years of Change in Accured Expenses readings, the most recent being $432777.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 40.64% to $432777.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $465753.0, a 8.01% increase, with the full-year FY2025 number at $465753.0, up 8.01% from a year prior.
  • Change in Accured Expenses hit $432777.0 in Q4 2025 for China Pharma Holdings, up from -$68702.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $804339.0 in Q4 2022 to a low of -$450887.0 in Q1 2023.
  • Median Change in Accured Expenses over the past 5 years was $83626.0 (2021), compared with a mean of $113112.2.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 579.2% in 2022 and later soared 940.44% in 2023.
  • China Pharma Holdings' Change in Accured Expenses stood at $207099.0 in 2021, then surged by 288.38% to $804339.0 in 2022, then crashed by 47.67% to $420886.0 in 2023, then skyrocketed by 73.24% to $729131.0 in 2024, then tumbled by 40.64% to $432777.0 in 2025.
  • The last three reported values for Change in Accured Expenses were $432777.0 (Q4 2025), -$68702.0 (Q3 2025), and $187274.0 (Q2 2025) per Business Quant data.